• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

Zeb2-NAT Molecule May Reverse Cellular Aging

cellular aging cellular regeneration

  • Please log in to reply
6 replies to this topic

#1 Iporuru

  • Guest
  • 216 posts
  • 221
  • Location:Europe

Posted 11 January 2018 - 06:53 PM


Researchers have found that by manipulating a single RNA molecule, they can reverse some aspects of cellular aging and regenerate aged cells.

 

Old cells resist regeneration

As we grow older, our cells gradually age, leading to the development of various diseases. Therefore, inducing cellular regeneration is one of the approaches that researchers are using to combat the age-related diseases associated with cellular aging. Unfortunately, aged cells are often highly resistant to therapies aimed at inducing regeneration.

Ribonucleic acid (RNA) is responsible for the creation of cellular proteins. However, a special type of molecule called non-coding RNA is never made into protein. In fact, when they mapped the human genome in 2001, they discovered that only around 2% of RNA is actually made into proteins.

Now, researchers have found a way to bypass the resistance of aged cells to being regenerated and becoming functionally more youthful.

 

What the study found out

In a recent Nature Communications paper, a team led by Dr. Bruno Bernardes de Jesus of the Instituto de Medicina Molecular (iMM) João Lobo Antunes in Lisboa discusses a technique that allowed the team to achieve easier cellular reprogramming of old fibroblasts into pluripotent cells[1].

Fibroblasts are connective tissue cells in animals that synthesize both the extracellular matrix, which is a “scaffolding” made up of extracellular molecules that provides structural and biochemical support to cells, and collagen, which is the main structural protein of connective tissues in animal bodies.

The study showed that the fibroblasts of old mice express higher levels of the transcription factor Zeb2. A transcription factor is a protein that regulates the DNA-to-messenger-RNA transcription rate, and Zeb2, in particular, induces epithelial cells to transition to mesenchymal cells. Epithelial cells are one of the four basic tissue types of animal cells, whereas mesenchymal cells are multipotent stem cells that give rise to fibroblasts, among others.

The synthesis of Zeb2 is controlled by the ribonucleic acid Zeb2-NAT (NAT stands for “natural antisense transcript”). What the scientists demonstrated in this paper is that by knocking down Zeb2-NAT in old mouse fibroblasts, Zeb2 can be downregulated significantly, which, in turn, leads to an enhanced fibroblast ability to turn into pluripotent cells rather than mesenchymal cells. The difference is that while mesenchymal cells can turn into only a certain range of related cells, pluripotent stem cells can turn into nearly all types of cells.

The way the researchers silenced Zeb2-NAT was by transfecting the fibroblasts with certain ribonucleic acid sequences—in other words, they introduced these sequences into the fibroblasts’ nuclei to modify their behavior.

Essentially, what they demonstrated is that aged cells that usually resist reprogramming can be regenerated by reducing the level of Zeb2-NAT without harming the cells’ developmental potency.

 

Conclusion

This study results spotlight the role of non-coding RNA in the fine-tuning and expression of protein-coding genes involved in pluripotency, differentiation, and reprogramming.

This opens the door for the regeneration of aged cells and tissues in an effort to prevent or reverse age-related diseases caused by cellular aging.

 

Literature

[1] Bernardes de Jesus, B., Pires Marinho, S., Barros, S., Sousa-Franco A., Alves-Vale, C., Carvalho, T., Carmo-Fonseca, M. (2018). Silencing of the lncRNA Zeb2-NAT facilitates reprogramming of aged fibroblasts and safeguards stem cell pluripotency. Nature Communications.

 

https://www.leafscie...cellular-aging/


  • Informative x 2
  • Cheerful x 1
  • Agree x 1

#2 Nate-2004

  • Guest
  • 2,375 posts
  • 357
  • Location:Heredia, Costa Rica
  • NO

Posted 11 January 2018 - 08:25 PM

Now how to do this in vivo.



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#3 HighDesertWizard

  • Guest
  • 830 posts
  • 788
  • Location:Bend, Oregon, USA

Posted 12 January 2018 - 12:49 PM

A few studies about ZEB2 and NF-kB...

 
 
The epithelial-to-mesenchymal transition (EMT) is a de-differentiation process that has been implicated in metastasis and the generation of cancer initiating cells (CICs) in solid tumors. To examine EMT in non-small cell lung cancer (NSCLC), we utilized a three dimensional (3D) cell culture system in which cells were co-stimulated with tumor necrosis factor alpha (TNF) and transforming growth factor beta (TGFβ). NSCLC spheroid cultures display elevated expression of EMT master-switch transcription factors, TWIST1, SNAI1/Snail1, SNAI2/Slug and ZEB2/Sip1, and are highly invasive. Mesenchymal NSCLC cultures show CIC characteristics, displaying elevated expression of transcription factors KLF4, SOX2, POU5F1/Oct4, MYCN, and KIT. As a result, these putative CIC display a cancer "stem-like" phenotype by forming lung metastases under limiting cell dilution. The pleiotropic transcription factor, NF-κB, has been implicated in EMT and metastasis. Thus, we set out to develop a NSCLC model to further characterize the role of NF-κB activation in the development of CICs. Here, we demonstrate that induction of EMT in 3D cultures results in constitutive NF-κB activity. Furthermore, inhibition of NF-κB resulted in the loss of TWIST1, SNAI2, and ZEB2 induction, and a failure of cells to invade and metastasize. Our work indicates that NF-κB is required for NSCLC metastasis, in part, by transcriptionally upregulating master-switch transcription factors required for EMT.
 
 
As a transcription factor, zinc finger E-box binding homeobox 2 (ZEB2) includes multiple functional domains which interact with kinds of transcriptional co-effectors. It has been reported that ZEB2 was involved in signal transduction and multiple cellular functions. However, the functional role of ZEB2 in inflammation is still obscure. The aim of the current study is to explore the function of ZEB2 in inflammation cytokine secretion and the role of the nuclear factor-κB (NF-κB) signaling pathway in lipopolysaccharide (LPS)-induced human proximal tubule cell line (HK-2) cells. Our result demonstrated that expression of ZEB2 was significantly downregulated and expression of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) was upregulated in response to LPS. Meanwhile, knockdown of ZEB2 by transfecting siRNA increased TNF-α and IL-6 secretion. Overexpression of ZEB2 resulted in a decrease of TNF-α and IL-6 secretion in HK-2 cells. Additionally, Western blot analysis indicated that ZEB2 suppressed the activation of the NF-κB signaling pathway viadownregulating the levels of phosphorylated p65 and IκBα compared with LPS stimulation. Collectively, our data demonstrated that ZEB2 attenuated LPS-induced inflammation cytokine secretion possibly through suppressing the NF-κB signaling pathway.

 

NF-kB is implicated in biological processes associated with ZEB2.

 

 

 

A few more studies related to reprogramming and NF-kB generally...

 

The role of NF-κB signaling in the maintenance of pluripotency of human induced pluripotent stem cells

 

NF-κB signaling plays an essential role in maintaining the undifferentiated state of embryonic stem (ES) cells. However, opposing roles of NF-κB have been reported in mouse and human ES cells, and the role of NF-κB in human induced pluripotent stem (iPS) cells has not yet been clarified. Here, we report the role of NF-κB signaling in maintaining the undifferentiated state of human iPS cells. Compared with differentiated cells, undifferentiated human iPS cells showed an augmentation of NF-κB activity. During differentiation induced by the removal of feeder cells and FGF2, we observed a reduction in NF-κB activity, the expression of the undifferentiation markers Oct3/4 and Nanog, and the up-regulation of the differentiated markers WT-1 and Pax-2. The specific knockdown of NF-κB signaling using p65 siRNA also reduced the expression of Oct3/4 and Nanog and up-regulated WT-1 and Pax-2 but did not change the ES-like colony formation. Our results show that the augmentation of NF-κB signaling maintains the undifferentiated state of human iPS and suggest the importance of this signaling pathway in maintenance of human iPS cells.

 

Inhibition of IKK/NF-κB Signaling Enhances Differentiation of Mesenchymal Stromal Cells from Human Embryonic Stem Cells

 

Embryonic stem cell-derived mesenchymal stromal cells (MSCs; also known as mesenchymal stem cells) represent a promising source for bone regenerative medicine. Despite remarkable advances in stem cell biology, the molecular mechanism regulating differentiation of human embryonic stem cells (hESCs) into MSCs remains poorly understood. Here, we report that inhibition of IκB kinase (IKK)/nuclear factor kappa B (NF-κB) signaling enhances differentiation of hESCs into MSCs by expediting the loss of pluripotent markers and increasing the expression of MSC surface markers. In addition, a significantly higher quantity of MSCs was produced from hESCs with IKK/NF-κB suppression. These isolated MSCs displayed evident multipotency with capacity to terminally differentiate into osteoblasts, chondrocytes, and adipocytes in vitro and to form bone in vivo. Collectively, our data provide important insights into the role of NF-κB in mesenchymal lineage specification during hESC differentiation, suggesting that IKK inhibitors could be utilized as an adjuvant in generating MSCs for cell-mediated therapies.

 

 

 

What are the implications of all this? What does it mean? Confused?

 

Dunno. Dunno. Yes.

 

But... We do know that NF-kB Inhibition increases survival probability odds. See the Survival Curves here.

 

 

 

The good news...

 

Focusing on NF-kB research places you at the very center of the research about aging cell reprogramming...

 

That's where we want to be, right?

 

:)

 


Edited by HighDesertWizard, 12 January 2018 - 12:52 PM.

  • Informative x 1

sponsored ad

  • Advert

#4 HighDesertWizard

  • Guest
  • 830 posts
  • 788
  • Location:Bend, Oregon, USA

Posted 12 January 2018 - 01:01 PM

2016

 

NF-κB signaling as a driver of ageing

 

NF-κB signaling exerts essential roles in immunity and cellular stress responses, regulating many functions related with organism innate defense. Besides, NF-κB altered signaling has been causally linked to ageing and diverse pathological conditions. We discuss herein the functional involvement of this signaling pathway in ageing, visiting recent experimental evidence about NF-κB activation in this complex process, its functional consequences and the novel biological functions raised from these works. Moreover, we discuss ageing intervention strategies based on NF-κB inhibition, which have demonstrated to be effective at delaying and even reverting different ageing manifestations in human and mouse models of both normal and accelerated ageing. Altogether, the current evidence supports that NF-κB activation constitutes a driving force of the ageing process and a preferential target for rejuvenation-aimed approaches.

 

Here's the outline of the study... Full text is available at sci-hub...

  1. Abstract
  2. Keywords
  3. Abbreviations
  4. 1. Introduction
  5. 2. NF-κB Signaling Pathway
    • 2.1. IKK Complex
    • 2.2. IκB Proteins
    • 2.3. NF-κB Transcription Factors
    • 2.4. Canonical and Noncanonical Signaling
  6. 3. NF-κB Activation in Ageing
  7. 4. Monitoring NF-κB Activity During Ageing
  8. 5. NF-κB Signaling in Ageing
    • 5.1. NF-κB Lessons From Progeroid Animal Models
      • 5.1.1. Sirt6-Deficient Mice
      • 5.1.2. Ercc1-Deficient Mice
      • 5.1.3. Zmpste24-Deficiency and LmnaG609G Mice
      • 5.1.4. Nfkb1-Deficient Mice
    • 5.2. NF-κB Secretory Phenotype
    • 5.3. NF-κB and Apoptosis
    • 5.4. NF-κB and Cellular Senescence
    • 5.5. NF-κB and Telomeres
    • 5.6. Immunosenescence
    • 5.7. NF-κB Crosstalk with Other Ageing Regulators
      • 5.7.1. Sirtuins
      • 5.7.2. Insulin-IGF-1 signaling
      • 5.7.3. mTOR
      • 5.7.4. FoxO (DAF-16)
      • 5.7.5. p53
      • 5.7.6. Wnt Signaling
      • 5.7.7. PARP-1
      • 5.7.8. Longevity Assurance Proteins
      • 5.7.9. Klotho
    • 5.8. NF-κB and Metabolism
    • 5.9. NF-κB in Age-Associated Pathologies
    • 5.10. NF-κB in Cell Reprogramming and Stem Cells Biology
    • 5.11. Fat Inflammatory Paradox
    • 5.12. NF-κB and Microbiota
  9. 6. NF-κB and Cancer
  10. 7. NF-κB as a Biomarker of Ageing
  11. 8. Rejuvenation Approaches Based on NF-κB Inhibition
  12. 9. Conclusions
  13. Acknowledgments
  14. References

 

 

I like this study a lot. But it neglects to mention an incredibly important body of evidence about NF-kB signaling, including evidence implicating survival probability odds.

 

What is that body of evidence?

 

:)


Edited by HighDesertWizard, 12 January 2018 - 01:23 PM.

  • Informative x 1

#5 HighDesertWizard

  • Guest
  • 830 posts
  • 788
  • Location:Bend, Oregon, USA

Posted 12 January 2018 - 01:20 PM

On the other hand, here's what Aubrey de Grey has to say...

 



#6 Nate-2004

  • Guest
  • 2,375 posts
  • 357
  • Location:Heredia, Costa Rica
  • NO

Posted 12 January 2018 - 01:55 PM

On the other hand, here's what Aubrey de Grey has to say...

 

About what? What part of the video?



Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).

#7 Pizzarulzz

  • Guest
  • 26 posts
  • 4
  • Location:India
  • NO

Posted 12 January 2018 - 03:03 PM

Nate, he is talking about inflammation





Also tagged with one or more of these keywords: cellular aging, cellular regeneration

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users